Equities research analysts predict that MEDNAX Inc (NYSE:MD) will post earnings of $0.90 per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for MEDNAX’s earnings, with the lowest EPS estimate coming in at $0.88 and the highest estimate coming in at $0.93. MEDNAX posted earnings per share of $0.92 in the same quarter last year, which would suggest a negative year over year growth rate of 2.2%. The company is scheduled to announce its next earnings results before the market opens on Thursday, February 20th.
On average, analysts expect that MEDNAX will report full year earnings of $3.36 per share for the current financial year, with EPS estimates ranging from $3.29 to $3.42. For the next year, analysts expect that the company will post earnings of $3.38 per share, with EPS estimates ranging from $3.20 to $3.48. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research firms that cover MEDNAX.
A number of equities analysts recently commented on the company. Mizuho set a $25.00 price target on MEDNAX and gave the stock a “hold” rating in a report on Friday, November 1st. Stifel Nicolaus upgraded MEDNAX from a “hold” rating to a “buy” rating and upped their price objective for the company from $25.00 to $33.00 in a research note on Thursday, December 12th. TheStreet downgraded MEDNAX from a “c-” rating to a “d” rating in a research note on Friday, November 1st. ValuEngine upgraded shares of MEDNAX from a “sell” rating to a “hold” rating in a report on Friday, January 3rd. Finally, Deutsche Bank began coverage on shares of MEDNAX in a report on Friday, January 3rd. They issued a “hold” rating and a $34.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. MEDNAX presently has a consensus rating of “Hold” and an average target price of $27.33.
Shares of NYSE MD traded down $5.62 during mid-day trading on Friday, hitting $20.97. The company had a trading volume of 181,566 shares, compared to its average volume of 947,871. The company has a market capitalization of $2.25 billion, a PE ratio of -1.20, a price-to-earnings-growth ratio of 1.04 and a beta of 0.84. The firm has a 50-day simple moving average of $26.39 and a two-hundred day simple moving average of $24.52. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 1.35. MEDNAX has a one year low of $19.93 and a one year high of $36.81.
MEDNAX Company Profile
MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services.
See Also: What is Forex?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.